Differences in sarcopenia prevalence between upper-body and lower-body based EWGSOP2 muscle strength criteria: the Tromsø study 2015–2016
Abstract Background The European Working Group on Sarcopenia in Older People (EWGSOP2) recommends grip strength and chair stand tests to be used as primary defining measures. It is unclear how either test affects prevalence estimates. Methods This cross-sectional study involved 3498 community-dwelli...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-11-01
|
Series: | BMC Geriatrics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12877-020-01860-w |
id |
doaj-3e2d31083d73424382947a4d9b8fc66c |
---|---|
record_format |
Article |
spelling |
doaj-3e2d31083d73424382947a4d9b8fc66c2020-11-25T04:09:53ZengBMCBMC Geriatrics1471-23182020-11-0120111110.1186/s12877-020-01860-wDifferences in sarcopenia prevalence between upper-body and lower-body based EWGSOP2 muscle strength criteria: the Tromsø study 2015–2016Jonas Johansson0Bjørn Heine Strand1Bente Morseth2Laila Arnesdatter Hopstock3Sameline Grimsgaard4Department of Community Medicine, UiT The Arctic University of NorwayDepartment of Chronic Diseases and Ageing, Norwegian Institute of Public HealthSchool of Sport Sciences, UiT The Arctic University of NorwayDepartment of Community Medicine, UiT The Arctic University of NorwayDepartment of Community Medicine, UiT The Arctic University of NorwayAbstract Background The European Working Group on Sarcopenia in Older People (EWGSOP2) recommends grip strength and chair stand tests to be used as primary defining measures. It is unclear how either test affects prevalence estimates. Methods This cross-sectional study involved 3498 community-dwelling participants (40–84 years) from the 7th Tromsø Study survey (2015–2016). We used grip strength, five-repetition chair stands, four-meter Walk Speed Test, Timed-Up-and-Go (TUG) and Dual-Energy X-ray Absorptiometry measurements. Data were analyzed using multiple linear regression models and ROC-curves. Results Probable and confirmed sarcopenia prevalence was 1.3 and 4.4% based on grip strength and chair stands, respectively. There was very low agreement between grip strength and chair stand cut-offs (κ = 0.07), with only 4.3% of participants defined as having probable sarcopenia overlapping in the two criteria. Participants with grip strength-based sarcopenia had lower mean height, weight, waist circumference, and appendicular lean mass relative to body height (ALMheight 2) than non-sarcopenic participants (all p < 0.001), after adjusting for multiple covariates. Conversely, participants with chair stand-based sarcopenia had similar height, higher weight, waist circumference and body fat% compared to non-sarcopenic participants (all p < 0.05). Area-under-curves (AUCs) for TUG-time were significantly larger when using chair stand instead of grip strength cut-offs (0.86, 95% CI 0.84–0.89 vs. 0.75, 95% CI 0.69–0.83). Conclusions Using chair stands instead of grip strength more than doubled probable sarcopenia prevalence across all ages. The two measures defined individuals of contradictory anthropometrics, body composition, and dissimilar physical function to have probable sarcopenia. Researchers should further evaluate the consequences of using different strength measures in the EWGSOP2 definition to classify sarcopenia.http://link.springer.com/article/10.1186/s12877-020-01860-wSarcopeniaPrevalenceEWGSOP2CohortThe Tromsø study |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jonas Johansson Bjørn Heine Strand Bente Morseth Laila Arnesdatter Hopstock Sameline Grimsgaard |
spellingShingle |
Jonas Johansson Bjørn Heine Strand Bente Morseth Laila Arnesdatter Hopstock Sameline Grimsgaard Differences in sarcopenia prevalence between upper-body and lower-body based EWGSOP2 muscle strength criteria: the Tromsø study 2015–2016 BMC Geriatrics Sarcopenia Prevalence EWGSOP2 Cohort The Tromsø study |
author_facet |
Jonas Johansson Bjørn Heine Strand Bente Morseth Laila Arnesdatter Hopstock Sameline Grimsgaard |
author_sort |
Jonas Johansson |
title |
Differences in sarcopenia prevalence between upper-body and lower-body based EWGSOP2 muscle strength criteria: the Tromsø study 2015–2016 |
title_short |
Differences in sarcopenia prevalence between upper-body and lower-body based EWGSOP2 muscle strength criteria: the Tromsø study 2015–2016 |
title_full |
Differences in sarcopenia prevalence between upper-body and lower-body based EWGSOP2 muscle strength criteria: the Tromsø study 2015–2016 |
title_fullStr |
Differences in sarcopenia prevalence between upper-body and lower-body based EWGSOP2 muscle strength criteria: the Tromsø study 2015–2016 |
title_full_unstemmed |
Differences in sarcopenia prevalence between upper-body and lower-body based EWGSOP2 muscle strength criteria: the Tromsø study 2015–2016 |
title_sort |
differences in sarcopenia prevalence between upper-body and lower-body based ewgsop2 muscle strength criteria: the tromsø study 2015–2016 |
publisher |
BMC |
series |
BMC Geriatrics |
issn |
1471-2318 |
publishDate |
2020-11-01 |
description |
Abstract Background The European Working Group on Sarcopenia in Older People (EWGSOP2) recommends grip strength and chair stand tests to be used as primary defining measures. It is unclear how either test affects prevalence estimates. Methods This cross-sectional study involved 3498 community-dwelling participants (40–84 years) from the 7th Tromsø Study survey (2015–2016). We used grip strength, five-repetition chair stands, four-meter Walk Speed Test, Timed-Up-and-Go (TUG) and Dual-Energy X-ray Absorptiometry measurements. Data were analyzed using multiple linear regression models and ROC-curves. Results Probable and confirmed sarcopenia prevalence was 1.3 and 4.4% based on grip strength and chair stands, respectively. There was very low agreement between grip strength and chair stand cut-offs (κ = 0.07), with only 4.3% of participants defined as having probable sarcopenia overlapping in the two criteria. Participants with grip strength-based sarcopenia had lower mean height, weight, waist circumference, and appendicular lean mass relative to body height (ALMheight 2) than non-sarcopenic participants (all p < 0.001), after adjusting for multiple covariates. Conversely, participants with chair stand-based sarcopenia had similar height, higher weight, waist circumference and body fat% compared to non-sarcopenic participants (all p < 0.05). Area-under-curves (AUCs) for TUG-time were significantly larger when using chair stand instead of grip strength cut-offs (0.86, 95% CI 0.84–0.89 vs. 0.75, 95% CI 0.69–0.83). Conclusions Using chair stands instead of grip strength more than doubled probable sarcopenia prevalence across all ages. The two measures defined individuals of contradictory anthropometrics, body composition, and dissimilar physical function to have probable sarcopenia. Researchers should further evaluate the consequences of using different strength measures in the EWGSOP2 definition to classify sarcopenia. |
topic |
Sarcopenia Prevalence EWGSOP2 Cohort The Tromsø study |
url |
http://link.springer.com/article/10.1186/s12877-020-01860-w |
work_keys_str_mv |
AT jonasjohansson differencesinsarcopeniaprevalencebetweenupperbodyandlowerbodybasedewgsop2musclestrengthcriteriathetromsøstudy20152016 AT bjørnheinestrand differencesinsarcopeniaprevalencebetweenupperbodyandlowerbodybasedewgsop2musclestrengthcriteriathetromsøstudy20152016 AT bentemorseth differencesinsarcopeniaprevalencebetweenupperbodyandlowerbodybasedewgsop2musclestrengthcriteriathetromsøstudy20152016 AT lailaarnesdatterhopstock differencesinsarcopeniaprevalencebetweenupperbodyandlowerbodybasedewgsop2musclestrengthcriteriathetromsøstudy20152016 AT samelinegrimsgaard differencesinsarcopeniaprevalencebetweenupperbodyandlowerbodybasedewgsop2musclestrengthcriteriathetromsøstudy20152016 |
_version_ |
1724421446005948416 |